Cc1ccc(O)c(-c2n[nH]c3c2C(c2ccccc2F)N(Cc2ccco2)C3=O)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?